Insiders Are Dumping These 5 Healthcare Stocks
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) is a clinical stage biopharma company that is working on treatments for endocrine-related diseases.
Inspire Medical Systems Inc. (INSP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 855,096 | $173,952,179 | +101% | 0.86% |
| 2. | Point72 Asset Management Steve Cohen | 473,195 | $96,262,059 | -47% | 0.23% |
| 3. | Eversept Partners Kamran Moghtaderi | 351,116 | $71,427,528 | +82% | 6.27% |
| 4. | Slate Path Capital David Greenspan | 294,000 | $59,808,420 | 1.32% | |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 247,641 | $50,377,609 | +2173% | 0.08% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $153.50 | 100 | Officer | 998 | 2023-10-12 | Filing | |
| $16.00 | 62,500 | Director | 631,451 | 2018-05-07 | Filing | |
| $16.00 | 312,500 | Large Shareholder, Director | 2,444,221 | 2018-05-07 | Filing | |
| $16.00 | 312,500 | Large Shareholder | 2,444,221 | 2018-05-07 | Filing | |
| $16.00 | 3,000 | Director | 3,000 | 2018-05-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $230.03 | 15,000 | Officer | 28,271 | 2024-04-17 | Filing | |
| $213.26 | 440 | Officer, Director | 63,658 | 2024-04-01 | Filing | |
| $210.99 | 232 | Officer, Director | 64,098 | 2024-04-01 | Filing | |
| $209.46 | 1,310 | Officer, Director | 64,330 | 2024-04-01 | Filing | |
| $208.34 | 1,492 | Officer, Director | 65,640 | 2024-04-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,257,544 | $662,682,190 | 0.05% | |
| 2. | 2,931,469 | $596,348,738 | 0.01% | |
| 3. | 1,800,207 | $366,216,270 | 0% | |
| 4. | 1,430,266 | $290,959,013 | 0.05% | |
| 5. | 1,229,879 | $250,194,284 | 0.2% |
News See All
Inspire Medical Systems, Inc. (NYSE:INSP) Q4 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Dilem, and I'll be your conference operator today.
Inspire Medical Systems (INSP) Experienced Volatility in 2023
Mairs & Power, an investment advisor, released the “Mairs & Power Small Cap Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Here’s Why Inspire Medical Systems (INSP) Underperformed the Broader Market
Headwaters Capital Management, an investment management company, released its fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
5 Best Mid-Cap Growth Stocks To Buy Now
California-based cybersec company SentinelOne Inc (NYSE:S) shares have gained about 56% over the past six months. Earlier this month SentinelOne Inc (NYSE:S) posted strong third quarter results.
15 Best Fast Growth Stocks to Buy Now
In this article, we will take a look at the 15 best fast growth stocks to buy now.
Inspire Medical Systems (INSP) Fell on Concerns about Weight Loss Drug
Chartwell Investment Partners, LLC, an affiliate of Carillon Tower Advisers, Inc., released the “Carillon Chartwell Small Cap Value Fund” third quarter 2023 investor letter.
Inspire Medical Systems (INSP) Fell on Growing Use of Weight Loss Drug
Wasatch Global Investors, an investment management firm, released its “Wasatch Small Cap Growth Strategy” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Should You Sell Inspire Medical Systems (INSP)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here.
Inspire Medical Systems (INSP) Fell on Fears Relating to Increasing Adoption of Weight Loss Drugs
Headwaters Capital Management, an investment management company, released its third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
